Back to Agendas
Accountable Care Organizations and Integrated Health Care
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons
BridgeBio, United States
This session will educate professionals in the pharmaceutical, biotechnology, and device industries and government employees on how medical and health economics data is disseminated to a variety of customer segments. Participants will benefit from understanding the opportunity and need to disseminate a variety of data to both the prescribing and decision maker communities.
This session was developed by the Medical Communications, Medical Science Liaison and Medical Writing Communities.
Learning Objective : Describe health economic and outcomes research including potential consumers of this research; Examine how health economic and outcomes research data is communicated to the expanded customer segments in this field; Identify the benefits and challenges of communicating health economics and outcomes research to a variety of customer segments.
Speaker(s)
Medical Communications Regarding Value and Outcomes to the Payer Audience
Christopher Marrone, PharmD, RPh
Eli Lilly and Company, United States
Outcomes Liaison Advisor – National Accounts, Value, Evidence and Outcomes (VEO)
Medical and Health Economics Data
Rudell Christian, DrPH, MPH
Pacira Pharmaceuticals, United States
Director, Health Outcome and Value Assessment, Medical Health Sciences
Medical Communications Regarding Value and Outcomes to the Decision Maker Audience
J. Lynn Bass, PharmD, RPh
BridgeBio, United States
Senior Director, Medical Science Liaisons
Have an account?